Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Endocrine 1

Conditions

Neoplasms 7Obesity 5Colorectal Neoplasms 5Breast Neoplasms 4Stroke 3Motor Activity 3Malnutrition 3Hypertension 3Diabetes Mellitus 3Prostatic Neoplasms 2Overweight 2Osteoporosis 2Kidney Diseases 2Heart Failure 2Frailty 2Colonic Neoplasms 2Cardiovascular Diseases 2Cachexia 2Arthritis 2Weight Loss 1Thinness 1Stomach Neoplasms 1Solid Tumors 1Sexual Dysfunction, Physiological 1Sedentary Behavior 1Sarcopenia 1Rectal Neoplasms 1Polycystic Ovary Syndrome 1Patient Compliance 1Overnutrition 1

Interventions

Everolimus 17lutetium Lu 177 dotatate 7Octreotide 7pasireotide 6lanreotide 6gallium Ga 68 dotatate 5Temozolomide 5Sunitinib 5Positron Emission Tomography Computed Tomography 5surufatinib 4pembrolizumab 4Sorafenib 4Data Collection 4Carboplatin 43-Iodobenzylguanidine 4Positron-Emission Tomography 3Nivolumab 3Etoposide 3Capecitabine 390Y-octreotide, DOTA-Tyr(3)- 3pentetreotide 2pazopanib 2lenvatinib 2fosbretabulin 2fluorodopa F 18 2cabozantinib 2avelumab 2arginyllysine 2Single Photon Emission Computed Tomography Computed Tomography 2Pemetrexed 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neuroendocrine Tumors × Nutrition Assessment × Clear all
NCT03143946 2024-05-06

DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor

University Medical Center Groningen

Phase NA Completed
53 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡